Seeking Men aged 13 to 40 years of age with Fragile X Syndrome for study of an investigational drug alone and/ or in combination with other drugs.
We are studying the effects of an investigational drug called Sulindac (HX02_01) and how safe and well this drug works alone or in combination with other drugs for male patients with Fragile X Syndrome.
What we're hoping for
Evaluate the safety and how well Sulindac works alone or in combination with other drugs in patients with Fragile X Syndrome
ClinicalTrials.gov Identifier: NCT04823052